Skip to content
← Back to this collection

PUBLICATIONS · 26427984

Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eye (Lond)
Publication date
2016 Jan
First author
Lumbroso-Le Rouic L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lumbroso-Le Rouic L
      type
      Author
    2. name
      Aerts I
      type
      Author
    3. name
      Hajage D
      type
      Author
    4. name
      Lévy-Gabriel C
      type
      Author
    5. name
      Savignoni A
      type
      Author
    6. name
      Algret N
      type
      Author
    7. name
      Cassoux N
      type
      Author
    8. name
      Bertozzi AI
      type
      Author
    9. name
      Esteve M
      type
      Author
    10. name
      Doz F
      type
      Author
    11. name
      Desjardins L
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lumbroso-Le Rouic L
      type
      Author
    2. name
      Aerts I
      type
      Author
    3. name
      Hajage D
      type
      Author
    4. name
      Lévy-Gabriel C
      type
      Author
    5. name
      Savignoni A
      type
      Author
    6. name
      Algret N
      type
      Author
    7. name
      Cassoux N
      type
      Author
    8. name
      Bertozzi AI
      type
      Author
    9. name
      Esteve M
      type
      Author
    10. name
      Doz F
      type
      Author
    11. name
      Desjardins L
      type
      Author
    bibliography ids
    1. nci-bib-cdd1d73154f7b073778eb750
    book metadata
    content sha256
    554768e2fe6f9def94ff90a03410d0e6d2be62ecbb1de4a1973d09b046355217
    document type
    citation
    dois
    1. 10.1038/eye.2015.179
    electronic publication date
    display
    2015 Oct 2
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26427984
    immutable id
    pubmed:26427984@554768e2fe6f9def94ff90a03410d0e6d2be62ecbb1de4a1973d09b046355217
    journal
    abbreviation
    Eye (Lond)
    issn electronic
    1476-5454
    issn print
    0950-222X
    issue
    1
    name
    Eye (London, England)
    nlm unique id
    8703986
    pages
    46-52
    volume
    30
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26427984
      provenance
      batch id
      4c1ece5bfc3d8e2be622
      provider
      NCBI PubMed ESummary
      record sha256
      be5f23e5db2d34f706f3d8ea8d91ceebd284a2dc773f9852f46144644c7c53d4
      response sha256
      85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
      retrieved at
      2026-09-09T23:47:12.730551+00:00
      publication date
      display
      2016 Jan
      precision
      month
      year
      2016
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26427984/
      title
      Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.

      Preserved source evidence · Not medical advice